Cargando…

Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease

INTRODUCTION: Evidence suggests that vascular inflammation and thrombosis may be important drivers of poor clinical outcomes in patients with COVID-19. We hypothesised that a significant decrease in the percentage of blood volume in vessels with a cross-sectional area between 1.25 and 5 mm(2) relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, Michael F., Pershad, Yash, Kang, Paul, Ridenour, Lauren, Lavon, Ben, Lanclus, Maarten, Godon, Rik, De Backer, Jan, Glassberg, Marilyn K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908189/ https://www.ncbi.nlm.nih.gov/pubmed/33632795 http://dx.doi.org/10.1183/13993003.04133-2020

Ejemplares similares

Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT
por: Lins, Muriel, et al.
Publicado: (2020)

Association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow up: A retrospective cohort study
por: Salerno, Daniel, et al.
Publicado: (2021)

Volume-outcome relationships for transcatheter aortic valve replacement-risk-adjusted and volume stratified analysis of TAVR outcomes
por: Verma, Divya Ratan, et al.
Publicado: (2017)

SIGNIFICANT DYSPNEA IN POST-ACUTE COVID-19 IS ASSOCIATED WITH ABNORMAL PULMONARY VASCULATURE ON CT DURING THE ACUTE PHASE
por: FLEITAS SOSA, DERLIS, et al.
Publicado: (2021)

The effect of posture on airflow distribution, airway geometry and air velocity in healthy subjects
por: Ides, Kris M., et al.
Publicado: (2022)

Functional respiratory imaging in relation to classical outcome measures in cystic fibrosis: a cross-sectional study
por: Lauwers, Eline, et al.
Publicado: (2021)

Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacity
por: Clukers, J., et al.
Publicado: (2018)

Pulmonary thromboembolic events in COVID‐19—A systematic literature review
por: Overton, Paul M., et al.
Publicado: (2022)

Pathway and network embedding methods for prioritizing psychiatric drugs
por: Pershad, Yash, et al.
Publicado: (2020)

Social Medicine: Twitter in Healthcare
por: Pershad, Yash, et al.
Publicado: (2018)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Genomewide Association Studies in Pharmacogenomics
por: McInnes, Gregory, et al.
Publicado: (2021)

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis
por: Lavon, Iris, et al.
Publicado: (2019)

Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy
por: Ricci, Fabrizio, et al.
Publicado: (2019)

Do alterations in pulmonary vascular tone result in changes in central blood volumes? An experimental study
por: Vos, Jaap Jan, et al.
Publicado: (2021)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
por: Mirsaeidi, Mehdi, et al.
Publicado: (2019)

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
por: Glaspole, Ian, et al.
Publicado: (2021)

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
por: Tashiro, Jun, et al.
Publicado: (2017)

Online, low-volume meditation does not alter immune-related biomarkers
por: Graham, Brett, et al.
Publicado: (2022)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
por: Vaknin-Dembinsky, Adi, et al.
Publicado: (2016)

Age‐dependent effects of thoracic and capillary blood volume distribution on pulmonary artery pressure and lung diffusing capacity
por: Coffman, Kirsten E., et al.
Publicado: (2018)

What Should Be Chronic: The Animal, the Model, or Both?
por: Rubio, Gustavo A., et al.
Publicado: (2016)

Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Liquid Biopsy in Gastrointestinal Cancers
por: Saini, Aman, et al.
Publicado: (2018)

“Putting it all together”: Highlighting the global approach to chronic total occlusion revascularization
por: Lazkani, Mohamad, et al.
Publicado: (2016)

Nonfatal Violent Workplace Crime Characteristics and Rates by Occupation — United States, 2007–2015
por: Siegel, Miriam, et al.
Publicado: (2020)

Two Cases Treated with Intravenous Iodine
por: Pershad, Ram
Publicado: (1925)

A Severe Case of Syphilis
por: Pershad, Ram
Publicado: (1924)

Safety and feasibility of obtaining wedged pulmonary artery samples and differential distribution of biomarkers in pulmonary hypertension
por: Fares, Wassim H., et al.
Publicado: (2012)

Pulmonary blood volume measured by cardiovascular magnetic resonance: influence of pulmonary transit time methods and left atrial volume
por: Nelsson, Anders, et al.
Publicado: (2021)

A Time-Varying Connectivity Analysis from Distributed EEG Sources: A Simulation Study
por: Ghumare, Eshwar G., et al.
Publicado: (2018)

Imaging Key Biomarkers of Tumor Angiogenesis
por: Backer, Marina V., et al.
Publicado: (2012)

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Do distribution volumes and clearances relate to tissue volumes and blood flows? A computer simulation
por: Hendrickx, Jan FA, et al.
Publicado: (2006)

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2020)

Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2021)

Pulmonary Biomarkers Based on Alterations in Protein Expression after Exposure to Arsenic
por: Lantz, R. Clark, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_q03c5jnq6oso76pr5bj376dgaf